REXAHN PHARMACEUTICALS, INC. 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jul 8, 2016
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-06+1,200,000→ 1,200,000 totalExercise: $0.26Exp: 2026-07-06→ Common Stock (1,200,000 underlying)
Footnotes (1)
- [F1]One quarter of the option vests and becomes exercisable on July 6, 2017, and, thereafter, 1/36th of the remaining option vests in equal installments on the first business day of each month following such date until fully vested.